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Blackcurrants are rich in polyphenolic glycosides called anthocyanins, which may inhibit postprandial glycemia. The aim was to determine the dose-
dependent effects of blackcurrant extract on postprandial glycemia. Men and postmenopausal women (14 M, 9 W, mean age 46 years, S.D.=14) were enrolled
into a randomized, double-blind, crossover trial. Low sugar fruit drinks containing blackcurrant extract providing 150-mg (L-BE), 300-mg (M-BE) and 600-mg
(H-BE) total anthocyanins or no blackcurrant extract (CON) were administered immediately before a high-carbohydrate meal. Plasma glucose, insulin and
incretins (GIP and GLP-1) were measured 0–120 min, and plasma 8-isoprostane F2α, together with arterial stiffness by digital volume pulse (DVP) was measured
at 0 and 120 min. Early plasma glucose response was significantly reduced following H-BE (n=22), relative to CON, with a mean difference (95% CI) in area over
baseline (AOB) 0-30 min of −0.34 mmol/l.h (−0.56, −0.11, Pb.005); there were no differences between the intermediate doses and placebo. Plasma insulin
concentrations (AOB 0–30 min) were similarly reduced. Plasma GIP concentrations (AOB 0–120 min) were significantly reduced following H-BE, with a mean
difference of −46.6 ng/l.h (−66.7, −26.5, Pb.0001) compared to CON. Plasma GLP-1 concentrations were reduced following H-BE at 90 min. There were no
effects on 8-isoprostane F2α or vascular function. Consumption of blackcurrant extract in amounts roughly equivalent to 100-g blackcurrants reduced
postprandial glycemia, insulinemia and incretin secretion, which suggests that inclusion of blackcurrant polyphenols in foods may provide cardio-metabolic
health benefits. This trial was registered at clinicaltrials.gov as NCT01706653.
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Evidence is emerging that fruit polyphenols may have wide-
ranging beneﬁcial effects on vascular andmetabolic health [1]. Among
the long list of potential fruit bioactives are the anthocyanins:
polyphenolic glycosides belonging to the ﬂavonoid family that vividly
pigment berries and other plant foods. The aglycones of anthocyanins,
anthocyanidins, include delphinidin, petunidin, cyanidin, malvidin,
pelargonidin and peonidin. Glycosylation can involve glucose, galac-
tose, rhamnose and arabinose or various combinations of these sugars.
There may also be acylation with p-coumaric, ferulic, caffeic, sinapic,
malonic, acetic or p-hydroxybenzoic acids. Blackcurrants are partic-
ularly rich in delphinidin-3-rutinoside, cyanidin-3-rutinoside,
delphinidin-3-glucoside and cyanidin-3-glucoside, as well as con-
densed tannins (proanthocyanidins), oligomeric and polymeric chains
of ﬂavan-3-ols [2].
Since dietary anthocyanins are derived from a relatively narrow
range of speciﬁc foods, average intakes are difﬁcult to establish from
short-term food records. Mean estimates from food frequency
questionnaires are 12.5 to 15.2 mg/d (IQR: 4.6–19.3 mg/d) in US
middle-aged and older men and women, mainly from strawberry ander the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Energy, nutrient and polyphenol composition of the test drinks
Per 200 ml H-BE M-BE L-BE CON
Energy and nutrients
Energy, kJ 92 90 90 95
Carbohydrate, g 4.6 4.5 4.5 4.8
Glucose, g 0.2 0.2 0.2 0.2
Fructose, g 0.2 0.2 0.2 0.2
Sucrose/Lactose/Maltose, g b0.1 b0.1 b0.1 b0.1
Starch, g 4.0 4.0 5.0 4.0
Fat, g 0.4 0.4 0.4 0.4
Protein, g b0.1 b0.1 b0.1 b0.1
Total dietary ﬁbre (AOAC), g b0.5 b0.5 b0.5 b0.5
Vitamin C, mg b0.5 b0.5 b0.5 b0.5
Vitamin E, mg b0.2 b0.2 b0.2 b0.2
Sodium, mg b3 b3 b3 b3
Potassium, mg 15.7 7.8 3.9 b3
Magnesium, mg 2.3 1.1 0.6 b0.4
Calcium, mg 6.5 3.3 b3 b3
Phosphorus, mg b2 b2 b2 b2
Zinc, mg b0.1 b0.1 b0.1 b0.3
Polyphenols
Total phenolics, mg1,2 1596 810 460 207
Total anthocyanins, mg1 599 322 131 46
Delphinidin-3-rutinoside, mg3 260 140 57 20
Cyanidin-3-rutinoside, mg3 209 113 46 16
Delphinidin-3-glucoside, mg3 76 41 17 6
Cyanidin-3-glucoside, mg3 33 18 7 3
H-BE: high blackcurrant extract; M-BE: medium blackcurrant extract; L-BE: low
blackcurrant extract; CON: no blackcurrant extract.
1 Total phenolic and anthocyanin content estimated from direct analysis of drinks
by Folin-Ciocalteau method and HPLC respectively.
2 Tannins added as an ingredient (H-BE 0 mg, M-BE 60 mg, L-BE 90 mg, CON
150 mg per 200-ml drink) to render drinks equivalent in bitter/astringent taste for
blinding purposes.
3 Estimated from HPLC analysis of raw extract, not direct analysis of the drinks.
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women,mainly fromgrapes, pears,wine, strawberries and raspberries
[4]. Epidemiological studies have reported that higher intakes of
anthocyanins are associated with a reduced risk of hypertension and
arterial stiffness [3,4] and lower markers of systemic inﬂammation
and insulin resistance [5]. In support of a beneﬁcial effect of habitual
anthocyanin intake on insulin resistance, higher intakes of berries (4 d
food records) at baselinewere associatedwith a reduced risk of Type 2
diabetes at followup (mean19.3 years) in a Finnish prospective cohort
of middle-aged and older men [6].
Ingestion of berry anthocyanins may have rapid effects on blood
glucose levels by delaying carbohydrate digestion and inhibiting the rate
of glucose absorption across the intestine [7–13], although proanthocya-
nidins are likely to be responsible for inhibition of α-amylase [13].
Randomized controlled trials suggest that consuming whole berries may
help control blood glucose concentrations [14–18], but the active
component is not yet clear.
The present study set out to test the hypothesis that drinks
containing an anthocyanin-rich blackcurrant extract would decrease
postprandial peak glucose concentrations following a carbohydrate
meal in a dose-dependent fashion, compared with a matched placebo
drink. Secondary outcomes included plasma insulin, GIP and GLP-1
response. Reducing postprandial glycemia may reduce markers of
oxidative stress and endothelial function [19,20]; therefore, changes in
indices of vascular function and plasma 8-isoprostane F2α concentra-
tions were also evaluated.
2. Subjects and methods
2.1. Subjects
Ethical approval for the study was obtained from King's College
London research ethics committee (reference BDM/11/12–88), and
written informed consent was given by participants. The trial was
carried out in accordance with the Declaration of Helsinki of 1975 as
revised in 1983 and registered at ClinicalTrials.gov (NCT01706653).
The aim was to recruit 22 subjects, allowing for four drop-outs to
complete 18 subjects, which would enable detection of a 1.6-mmol/l
difference in glucose incremental Cmax, assuming 80% power
(estimated from Torronen et al. [17] treatment group S.D. of 1.3 to
1.5 mmol/l for Cmax, rho=0.1), using a paired t test with an alpha
0.017 (allowing for three-way comparisons). Social networking Web
site advertisements and a circular email within King's College London
were used for recruitment, which was initiated in August 2012. A
participant information sheet was provided to volunteers who
expressed interest. Participants, recruited from King's College London
and from the general public in the London area, attended the
Metabolic Research Unit at the Diabetes & Nutritional Sciences
Division, King's College London, in a fasting state for a screening
appointment which included the measurement of height, weight,
waist circumference, % body fat (by bioelectrical impedance using the
Tanita™ Body Composition Analyser), seated blood pressure, liver
function tests, glucose, lipid proﬁle and haematology. A small
remuneration was given for participation in the study. Inclusion
criteria were healthy men aged 20–60 years and postmenopausal
women aged 45–60 years, BMI 18–35 kg/m2, able to understand the
information sheet and willing to comply with study protocol and able
to give written informed consent. Women aged 45 years or older who
reported not having had a period for 12 months or longer were
deﬁned as postmenopausal. Exclusion criteria were as follows:
phenylketonuria; allergy, hypersensitivity or intolerance to any
foods/food ingredients; participation in another clinical trial; those
with full blood counts and liver function tests outside of the normal
range; current smokers or those who gave up smoking within the last
6 months; reported medical history of cardiovascular disease, cancer,liver, kidney or bowel disease; fasting glucose≥7.1 mmol/l or
uncontrolled Type 2 diabetes; presence of gastrointestinal disorder
or use of drug which is likely to alter gastrointestinal motility or
nutrient absorption; history of substance abuse or alcoholism;
unwilling to restrict consumption of speciﬁed high polyphenol foods
for 24 h before the study; weight change of N3 kg in preceding
2 months; body mass indexb18 and N35 kg/m2; fasting blood
cholesterol≥7.5 mmol/l; fasting TAG≥5 mmol/l; blood pressure≥160/
100 mmHg; current use of medications that may interfere with the
study such as alpha-glucosidase inhibitors (e.g., acarbose), insulin-
sensitizing drugs (e.g., metformin, thiazolidinediones), sulfonylureas,
and lipid-lowering drugs; current use of nutritional supplements that
may interfere with the study such as higher dose vitamins/minerals
(N200% RNI), B vitamins, Vitamin C, calcium, copper, chromium,
iodine, iron,magnesium,manganese, phosphorus, potassiumand zinc.
2.2. Study design
A randomized, double-blind, crossover design was used to
compare four test drinks, with study visits scheduled at least 1 week
apart. Each test drink consisted of a “no added sugar” fruit drink with
increasing doses of blackcurrant extract added to it, providing 90 kJ,
b0.1-g protein, b5-g carbohydrate and 0.4-g fat. The blackcurrant
extract (BerryPharma® by Iprona AG, Lana, Italy) contained 5775-mg
total polyphenols per 100-ml extract (2822-mg total anthocyanins per
100 ml), analysed by RSSL The Lord Zuckerman Research Centre
(Reading, UK); see Table 1. The drinks were formulated by Döhler
(Milton Keynes, UK) and GlaxoSmithKline Nutritional Healthcare R&D
(Coleford, UK), later to become Lucozade Ribena Suntory (Uxbridge,
UK), and standardized to contain 600-mg anthocyanins (H-BE), 300-
mg anthocyanins (M-BE) or 150-mg anthocyanins (L-BE). The placebo
drink did not have any blackcurrant extract added to it (CON), but M-
BE, L-BE andCONwere adjustedwith added tannins to ensure blinding
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bitterness in taste. This meant that CON also contained tannin
polyphenols. The standardized high carbohydrate meals consumed
on each study visit consisted of 100-g thick sliced white bread (Hovis,
London, UK) with 32-g Hartley's smooth apricot jam (Hain Daniels
Group, Leeds, UK), both high carbohydrate foods which are low in
phenolics (b6-mg/100-g fresh weight) [2], to provide 1127-kJ energy,
62-g carbohydrate, 39-g starch, 23-g sucrose. The total carbohydrate
intake including the test drink was 67 g. The randomization schedule
was generated by independent contracted parties within GlaxoS-
mithKline Nutritional Healthcare, and allocation to treatment se-
quence was carried out once a participant was determined to be
eligible and had agreed to take part in the study according to the
schedule of randomly generated treatment sequences. Allocation of
treatment at each visit was blinded from the investigators, laboratory
technicians, statisticians and the study participants.
The participants consumed each of the four test drinks delivered in
opaque bottles and consumed with a straw within 2 min, in random
order, after baseline measurements/blood samples were taken. The
mixed carbohydratemealwas consumed immediately after consump-
tion of the drink, within 5 min. Each test meal protocol (Fig. 1) was
separated by at least 1 week.
On the day preceding each test meal, participants were told not to
participate in strenuous exercise and to avoid alcohol, caffeine, oily ﬁsh,
high polyphenol foods (from a list provided) and foods high in fat. They
were providedwith a standardized low-fatmeal (containing b10 g fat) as
their evening meal, which they were required to consume before 20 h
and then to avoid eating or drinking anything except for water until the
study visit (a 12-h fast). Participants attended themetabolic research unit
between 08 h and 10 h 30 min the next day. They were asked to empty
their bladder, be weighed and then rest in a supine position in a
temperature-controlled, quiet, dim room for 10 min before blood
pressure and digital volume pulse (DVP) measurements were taken. A
cannula was inserted into the forearm antecubital vein, and blood was
collected for baseline analysis (in duplicate at −15 and −10 min for
glucose). Following consumption of the test meal, further venous blood
sampleswere collected10, 20, 30, 45, 60, 75, 90 and120 minafter the test
drink/meal for plasma glucose, insulin, NEFA, GIP, GLP-1 and TAG analysis
and at 120 min only for 8-isoprostane F2α analysis. Blood pressure/
vascular measurements were made within 10 min after the ﬁnal blood
sample had been taken at 120 min. Participants had access towater to sip
as required over the 2-hperiod. Adverse eventswere recorded at all study
visits where necessary by asking the following question during each visit,
including any follow-up visits or telephone calls and documenting the
reply: “Have you felt unwell, experienced any symptoms or taken any
medication today or since the last session?”2.3. Methods
Blood samples for plasma GIP and GLP-1 analysis were collected
into EDTA tubes (Becton Dickinson, UK) and centrifuged at 1300 ×gFig. 1. Study visitfor 15 min at 4 °C, and plasma was stored at −80 °C until analysis.
EDTA tubes for GLP-1 analysis had 10 μl per ml blood dipeptidyl
peptidase iv inhibitor added (Millipore,MO, USA). GIP andGLP-1were
determined by ELISA kits (Millipore Corporation, MA, USA). Further
blood samples were collected into ﬂuoride oxalate tubes for glucose
analysis and SST™ II tubes for TAG, insulin and NEFA analysis; plasma
and serum were stored frozen at −40 °C until analysis (Becton
Dickinson, UK). Enzymatic assays were used to determine concentra-
tions of NEFA, glucose and TAG (TAG and glucose: Instrumentation
Laboratory, cat.no. 0,018,255,640 and cat.no. 00,018,250,740,
Warrington, Cheshire, UK; NEFA C: Wako Chemicals GmbH, cat.no.
999–75,406, Neuss, Germany) on an ILAB-650 analyser (Instrumen-
tation Laboratory, Warrington, UK). Blood for 8-isoprostane-F2α
analysis was drawn into chilled citrated tubes (Becton Dickinson,
UK), and chilled fresh indomethacin (cyclooxygenase inhibitor) was
immediately added (ﬁnal concentration 15 μmol/l). The sample was
kept on ice 30 min prior to centrifugation at 2400 ×g for 15 min. BHT
was added (ﬁnal concentration 20 μmol/l), and the samples were
frozen in liquidN2 and stored at−80 °C until analysis of 8-isoprostane
F2α by GC/MS as previously described [21].
Blood pressure was measured according to British Hypertension
Society guidelines using an automated upper arm blood pressure
monitor, the Omron 705IT (Omron Healthcare Europe B.V.). DVP was
obtained by photoplethysmography (PulseTrace, Micro Medical Ltd.,
Kent, UK) and used to calculate stiffness index (DVP-SI, m/s) and
reﬂection index (DVP-RI, %).2.4. Statistical analyses
Mean values for plasma glucose concentrations were calculated
from duplicate measurements made at baseline (−15 and−10 min)
before statistical analysis. A linear mixed effects model was used to
analyse incremental Cmax and AOB using PROC MIXED in SAS
software (Marlow, UK). Main effects of drink and drink × time
interactions for the change from baseline at each time point were
calculated by linear mixed effects modelling using SPSS Statistics
Version 21 (IBM, UK). The models included subject as a factor (a
random effect), ﬁxed factors were drink (and time and drink × time
interaction where appropriate) and period. Baseline values and two
baseline termswere included as covariates: (a) subject-level baseline;
the number of valid responses calculated as the mean baseline across
all periods within a subject, and (b) the period-level baseline minus
the subject-level baseline. P-values were adjusted using Dunnett's
procedure for the comparison against a control (reference) product,
either using SAS for incremental Cmax and AOB, or using two-way
repeated measures ANOVA in GraphPad Prism Version 6.00 for
Windows (GraphPad software, CA, USA) for drink and drink × time
effects (since SPSS does not provide Dunnett's multiple testing
adjustment in the linear mixed model facility with repeated
measures). The assumption of normality and homogeneity of variance
was investigated. Violation of these assumptions were overcomeprotocol.
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were analysed by Friedman's nonparametric test using GraphPad Prism.3. Results
Thirty volunteers who met the initial eligibility criteria following a
telephone questionnaire attended screening sessions at King's College
London, of whom 4 did not meet inclusion criteria. Of the 26 eligible
participants, 22 were randomized to treatment and completed the
study. All completing subjects were fully compliant with the study
protocol. Details are shown on the consort diagram (Fig. 2). The
characteristics of thosewho completed the study are shown in Table 2.
There were three treatment emergent adverse events: one was
considered treatment-related (discoloured faeces following CON),
and the others (following H-BE) were related to cannulation site
discomfort. No adverse events were considered serious.Fig. 2. Consort3.1. Glucose, insulin and incretins
The postprandial changes in plasma glucose after the test drinks and
standard carbohydrate meals are shown in Fig. 3A. An overall drink effect
for the change from baseline of (Ln)glucose concentrations 0–120 min
(Pb.05) was observed, with no statistically signiﬁcant drink × time
interaction for postprandial glucose response (P=.16). As Fig. 3A
illustrates, H-BE inhibited glucose concentrations during the initial
30 min of the postprandial period (AOB 0–30 min mean difference H-BE
vs. CON (95% CI) −0.34 mmol/l.h (−0.56, −0.11, Pb.005); AOB
0–120 min were not signiﬁcantly different between meals. Post hoc
pairwise comparisons showed that there were signiﬁcantly lower glucose
concentrations following H-BE compared to CON at 10–30 min postdrink
(Fig. 3A), and there was a statistically signiﬁcant increase in glucose
followingH-BE at 75 min relative to CON(meandifference in change from
baseline values was 0.72 mmol/l (0.18, 1.25; Pb.01). Cmax (adjusted for
baseline)was not signiﬁcantly different betweenmeals. Tmaxwas slightlydiagram.
Table 2
Characteristics of healthy subjects who completed the study (n=22)a
Variable
Age, year 45.4 (13.7)
Sex, male to female ratio 13:9
Body mass index, kg/m2 25.5 (3.8)
Systolic blood pressure, mmHg 122.7 (14.1)
Diastolic blood pressure, mmHg 77.2 (10.8)
Waist circumference, cm
Males 88.3 (9.6)
Females 89.2 (13.9)
Body fat, %
Males 18.1 (6.2)
Females 35.1 (8.2)
Fasting plasma glucose, mmol/l 5.4 (0.5)
Fasting plasma triacylglycerol, mmol/l 1.2 (0.5)
Fasting plasma total cholesterol, mmol/l 4.9 (1.0)
Fasting plasma LDL cholesterol, mmol/l 2.8 (0.8)
Fasting plasma HDL cholesterol, mmol/l 1.5 (0.4)
Males 1.3 (0.4)
Females 1.7 (0.3)
a Values are means (S.D.). A
B
Fig. 3. Postprandial plasma glucose and insulin concentrations. Mean (±S.E.M.) plasma
glucose (A) and insulin (B) concentrations following ingestion of four low sugar fruit
drinks 2min before consuming amixed carbohydratemeal, in randomized order: H-BE:
high blackcurrant extract; M-BE: medium blackcurrant extract; L-BE: low blackcurrant
extract; CON: placebo. N=22. All data were natural log transformed before mixed
model analysis. For glucose Pb.001 for an overall drink effect on changes from baseline,
and for insulin, Pb.001 for a drink effect and Pb.001 for a drink x time interaction on raw
values and changes from baseline. (A) post hoc analysis of timepoint differences in
change from baseline in glucose compared to CON with Dunnett's adjustment: aPb0.05
for the difference between H-BE and CON andM-BE and CON; bPb.005 for the difference
between H-BE and CON; cPb0.01 for the difference between H-BE and CON. (B) post hoc
analysis of timepoint differences in change from baseline in insulin with Dunnett's
adjustment: aPb.005 for the difference between H-BE and CON; bPb0.01 for the
difference between H-BE and CON; cPb0.05 for the difference between H-BE and CON.
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L-BE andCON(meanswere 46 min, 39, 62; 49 min, 42, 57; 48 min, 36, 60,
respectively), but this did not reach statistical signiﬁcance (P=.06).
There was a statistically signiﬁcant drink effect (Pb.001) and drink ×
time interaction (Pb.05) for (Ln)insulin 0–120 min, and a drink × time
interaction (Pb.05) for the change frombaseline in (Ln)insulin0–120 min.
Post hoc analysis showed similar temporal drink differences to glucose
(Fig. 3B), with signiﬁcantly lower insulin concentrations initially,
following H-BE compared to CON, at 10, 20 and 30 min, and higher
concentrations at 75 and 90 min (Fig. 3B). The mean difference in AOB
0–30 min between H-BE and CON (95% CI) was−8.77 mU/l.h;−13.86,
−3.68, Pb.005. There were no differences in Cmax, Tmax and AOB
0–120 min for insulin.
Plasma GIP changes from baseline concentration were signiﬁcantly
reducedduring thewholepostprandialmeasurementperiod followingH-
BE anthocyanins compared to CON, with a signiﬁcant decrease in Cmax
(mean difference, −64.4 ng/l; −95.5, −33.4; Pb.0005) and AOB
0–120 min (Pb.0001) and highly statistically signiﬁcant drink effect
(Pb.0001) and drink × time interaction (Pb.005) on (Ln)GIP 0–120 min
and change from baseline of (Ln)GIP 0–120 min (drink effect Pb.0001).
Post hoc pairwise comparisons with Dunnett's adjustment for multiple
comparisons showed consistently reduced plasma GIP concentrations at
all timepoints following H-BE up until 90 min (Fig. 4A).
Plasma GLP-1 concentrations were also reduced by H-BE (Fig. 4B),
with a statistically signiﬁcant drink effect on changes from baseline of
(Ln)GLP-1 (Pb.0005) but no signiﬁcant drink × time interaction. Post
hoc pairwise comparisons showed reduced plasma GLP-1 concentra-
tions relative to baseline following H-BE compared to CON and L-BE
anthocyanins at 90 min (Fig. 4B). There were no differences in Cmax,
Tmax and AOB 0–120 min for GLP-1.
3.2. Lipids
Plasma TAG concentrations [(Ln)TAG up to 120 min] were signiﬁ-
cantly different according to drink, but this was due to a signiﬁcant
difference at baseline (Pb.005), and the changes from baseline (Ln)TAG
did not differ (Supplementary Fig. 1A). There was no effect of drink on
plasma NEFA concentrations (Supplementary Fig. 1B).
3.3. Isoprostanes and vascular function
(Ln)8-isoprostane F2α concentrations, blood pressure, DVP-SI and
DVP-RI changes from baseline were not signiﬁcantly different
between drinks (Table 3).4. Discussion
This study aimed to investigate whether blackcurrant
anthocyanin-rich fruit drinks could inhibit the rise in blood glucose
concentrations following a high-carbohydrate meal in a healthy
population. The highest dose of blackcurrant anthocyanins inhibited
the rate of the increase in plasma glucose, and insulin concentrations
in the ﬁrst 30 min had an inhibitory effect on plasma GIP concentra-
tions up to 90 min postmeal and reduced plasma GLP-1 concentra-
tions at ~90 min, but the lower doses had no signiﬁcant inhibitory
effects. This delaying effect on postprandial glycemia may, if
experienced habitually over many years, reduce risk of developing
insulin resistance and, eventually, Type 2 diabetes [22]. H-BE was
equivalent to approximately 100-g fresh raw blackcurrants [2], which
could conceivably be consumed without discomfort at one sitting.
Furthermore, there tended to be a rebound effect on plasma glucose
and insulin concentrations in the later timepoints, with the highest
AB
Fig. 4. Postprandial plasma GIP and GLP-1 concentrations. Mean (±S.E.M.) plasma GIP
(A) and GLP-1 (B) concentrations following ingestion of four low sugar fruit drinks 2
min before consuming a mixed carbohydrate meal, in randomized order: H-BE: high
blackcurrant extract (GIP n=17; GLP-1 n=20); M-BE: medium blackcurrant extract
(GIP n=20; GLP-1 n=22); L-BE: low blackcurrant extract (GIP n=20; GLP-1 n=21);
CON: placebo (GIP n=19; GLP-1 n=22). All data were natural log transformed before
mixedmodel analysis. For GIP, therewas an overall drink effect on raw values (Pb.0001)
and changes from baseline (Pb.0001) and a drink × time interaction on raw values
(Pb0.005), and for GLP-1, there was an overall drink effect on raw values and changes
from baseline (Pb.001). (A) post hoc analysis of timepoint differences in change from
baseline in GIP with Dunnett's adjustment: aPb0.0001 for the difference between H-BE
and CON and bPb0.001 for the difference between L-BE and CON; cPb0.0005 for the
difference between H-BE and CON; dPb0.005 for the difference between H-BE and L-BE
and H-BE and M-BE; ePb0.05 for the difference between H-BE and CON; and fPb0.0005
for the difference between H-BE and CON. (B) post hoc analysis of timepoint differences
in change from baseline in GLP-1 with Dunnett's adjustment: aPb0.05 for the difference
between H-BE and CON.
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observed previously with whole berry purée and nectar [15,16]. This
did not translate to the same pattern in the incretin levels, which
consistently showed reduced concentrations following the highest
dose compared to placebo throughout the 120-min postprandial
period. No changes in secondary outcome variables related to lipids,
vascular function or oxidative stress were observed.
These data are in agreement with previous reports that whole
berry meals or berry nectars (juices) rich in anthocyanins, including
those derived from blackcurrants, inhibited plasma glucose and
insulin concentrations in the ﬁrst 30 min following consumption
[14–17,23]. Furthermore, these results provide novel data showingthat a liquid blackcurrant extract (devoid of ﬁbre and low in other
confounding nutrients) not only lowers glucose and insulin concen-
trations but also inhibits incretin secretion. The observation that GLP-1
secretionmay be inhibited in the latter half of the postprandial period
is in contrast to a previous study of amixed berrymeal consumedwith
sucrosewhich showed that plasmaGLP-1 concentrationswere slightly
increased in the ﬁrst hour following consumption of the meal [16],
which might reﬂect differences in study design such as the solid state
of the carbohydrate load andmixed sucrose and starch composition of
the present test meal.
The difference in carbohydrate type and physical state of the testmeal
might also explain why a previous study observed a return to baseline of
insulin concentrations following their referencemeal (sucrose andwater)
[15],whereas plasma insulin concentrations remained elevated following
our control and blackcurrant extract test meals (drink, followed by bread
and apricot jam). Consequently, the insulin-mediated suppression of
circulating NEFA concentrations was not different in the current study, in
contrast to the previous study which observed an inhibition of the
upwards return to baseline in plasma NEFA concentrations around
90–120 min following blackcurrant puree and blackcurrant juice, in line
with higher insulin concentrations at these times points in comparison to
the reference meal [15].
Inhibition of intestinal glucose transporters (e.g., SGLT1, GLUT2)
and inhibition of digestive enzymes are the primary proposed
mechanisms by which blackcurrant polyphenols might act on
glycaemic response [10,24,25], although delayed gastric emptying
cannot be ruled out. Polyphenolic components of blackcurrant extract
such as proanthocyanidins may reduce pancreatic α-amylase activity
in the duodenum by binding to the protein [13]. Additional inhibition
of carbohydrate digestion may occur by interaction of anthocyanins
and other blackcurrant polyphenols with intestinal brush border α-
glucosidases, resulting in reduced maltase and sucrase activities [8].
Since our control drink and lower dose intervention drinks also
contained added tannins in order to match the bitter taste of H-BE,
there is likely to have been inhibition of α-amylase across all test
drinks. Thus, differences observed here are possibly related to
anthocyanin content. Anthocyanins can also be transported into the
intestinal cell using the SGLT1 transporter, and competition for this
route following an anthocyanin-richmeal may inhibit rates of glucose
absorption, in a similar way to phlorizin (a dihydrochalcone in apple
that inhibits SGLT1-mediated glucose uptake) [26,27].
The strong inhibition of plasma GIP concentrations throughout the
postprandial period suggests that secretory regulation of this incretin
is highly sensitive to glucose absorption rates. SGLT1 has been shown
to be coexpressed with GLP-1 and GIP in individual enteroendocrine
cells of murine jejunal crypts, and studies in Sglt1−/− mice have
shown the essential role of SGLT1 as a glucose sensor for GIP andGLP-1
secretion [28], although GLUT2 may also be an important regulator of
incretin response [29]. Our human data showing inhibition of
carbohydrate-induced incretin secretion following consumption of
blackcurrant polyphenols mirror previous reports of phlorizin
sensitivity of glucose-induced SGLT1-mediated incretin release [30].
The suppression of plasma GLP-1 concentrations by the top dose of
blackcurrant extract paradoxically coincided with the time point
where plasma insulin concentrations were increased relative to
placebo, at 90 min postdrink. Polyphenol-induced delayed digestive
processing of the starch/sucrose test meal is likely to have resulted in
partially digested dextrins and disaccharides possibly shifting further
down the small intestine. This may have increased the proportion of
glucose that was absorbed later (75–90 min) relative to control
accounting for the crossover in glucose and insulin proﬁles, in
agreement with glycaemic/insulinaemic proﬁles observed previously
[15–17]. GLP-1 is released from L cells in the distal intestine within
minutes of nutrient ingestion via neuroendocrine signalling, but
inhibition by blackcurrant extract occurred around the time that the
Table 3
Effects of blackcurrant extract and placebo test drinks on digital volume pulse (DVP), systolic and diastolic blood pressure (SBP and DBP) and plasma 8-isoprostane F2α in healthy men
and postmenopausal women1
CON L-BE M-BE H-BE
DVP-RI, % Baseline 74.4 (69.5, 79.2) 70.4 (64.8, 76.1) 72.9 (67.1, 78.6) 72.8 (68.0, 77.5)
Δ120 min -0.57 (−5.35, 4.21) 3.80 (−0.93, 8.54) 0.15 (−4.26, 4.56) 1.38 (−3.28, 6.04)
DVP-SI, m/s Baseline 8.57 (7.75, 9.40) 8.50 (7.63, 9.37) 8.44 (7.64, 9.25) 8.71 (7.62, 9.80)
Δ 120 min -0.75 (−1.44,−0.05) -0.23 (−1.05, 0.59) -0.57 (−1.21, 0.07) -0.55 (−1.54, 0.45)
SBP, mmHg Baseline 120.8 (116.1, 125.2) 120.9 (115.6, 126.0) 120.7 (116.0, 125.5) 118.3 (113.7, 122.9)
Δ 120 min -4.5 (−8.8,−0.1) -1.0 (−6.8, 4.9) -5.2 (−8.9,−1.5) -1.7 (−6.7, 3.3)
DBP, mmHg Baseline 74.6 (71.2, 78.1) 75.3 (71.7, 78.9) 74.5 (71.3, 77.8) 73.6 (70.8, 76.4)
Δ 120 min -0.6 (−4.3, 3.2) 1.7 (−2.0, 5.4) -1.1 (−3.6, 1.3) 0.5 (−2.5, 3.5)
Plasma 8-isoprostane F2α, pmol/L2 Baseline 86.4 (68.8, 108.4)3 123.7 (96.6, 158.3)3 100.5 (80.8, 125.1) 98.4 (76.6, 126.2)
Δ 120 min 1.13 (1.01, 1.27) 0.94 (0.81, 1.09) 1.02 (0.91, 1.14) 0.97 (0.85, 1.11)
H-BE: high blackcurrant extract (600-mg anthocyanins); M-BE: medium blackcurrant extract (300-mg anthocyanins); L-BE: low blackcurrant extract (150-mg anthocyanins); CON:
placebo (0 mg anthocyanins). No signiﬁcant differences were observed between drinks.
1 Values are mean baseline values and changes from baseline measured 120 min after the test drink and mixed carbohydrate meal (95% CI), n=22.
2 Values are geometric mean baseline values and log ratios of changes from baseline measured 120 min after the test drink and mixed carbohydrate meal (95% CI), n=22.
3 n=20 due to sample loss.
160 M.L. Castro-Acosta et al. / Journal of Nutritional Biochemistry 38 (2016) 154–161meal contents would be reaching the part of the jejunum where the
secretory cells are located suggesting a direct inhibition of glucose
transport in this part of the gut by the blackcurrant polyphenols.
No acute differences in blood pressure, arterial stiffness or pulsewave
reﬂection index as measured by DVP were observed between drinks,
consistent with previous vascular observations following single meals
[31,32]. This does not exclude the possibility that theremight be an effect
of blackcurrant polyphenols on vascular function. Anthocyanins rapidly
appear in the circulation 1–2 h after consumption at very low
concentrations (1–150 nmol/l for intakes of 3–1200 mg) [33,34] and
are equally rapidly cleared, so are unlikely to have a signiﬁcant impact on
vascular function early in the postprandial period [35], although black-
currant phenolic acids that peak around 2 h post ingestion might be
associated with some improvement in endothelial function [31].
However, colonic metabolites, conjugated phenolic acids, would be
expected to appear in the circulation 4–12 h post ingestion andmay also
be bioactive in this respect [33]. Acute episodes of high blood glucose
cause endothelial dysfunction in animalmodels andhealthy volunteers in
clinical trials, with hyperglycemia-induced oxidative stress as the most
likely mediator [19,36]. However, the different proﬁles of postprandial
glycemia observed here were not associated with any signiﬁcant
differences in a sensitive marker of lipid peroxidation, 8-isoprostane F2α.
The strengths of this study include the rigorous adherence to
double blinding until ﬁnal statistical analysis was complete, random-
ization and allocation concealment being conducted at a remote site
by an independent party and the control drink was fully matched to
the intervention drinks for taste, appearance and nutrient composi-
tion. The studywas carried out in a broad cross-section of healthymen
and postmenopausal women, although premenopausal women were
excluded to avoid confounding effects of reproductive hormones [37].
Limitations of the study include the fact that the difﬁculty in ﬁnding a
bitter/astringent taste additive that is not a potentially bioactive
compoundmeant that tanninswere added to placebo and lower doses
of blackcurrant extract drinks for taste blinding. Although we
observed signiﬁcant inhibition of glycemia, insulinemia and incretin
secretion, the true size of the effect may have been much larger if the
requirement for blinding had not necessitated addition of tannins.
Serum concentrations of anthocyanins and their metabolites were not
measured in this study since the primary aimwas to investigate effects
on postprandial glycaemia, mainly determined by polyphenol inter-
actions with digestive enzymes and intestinal glucose transporters
within the lumen of the gastrointestinal tract. However, interpretation
of some of the secondary outcome variables (vascular function and
blood pressure) would have been aided by data on circulating
blackcurrant polyphenol derivatives.In conclusion, anthocyanin-rich blackcurrant extract, providing a
similar quantity of polyphenols to that found in ﬁve heaped tablespoons
of blackcurrants, delayed the appearance of glucose in the blood and
inhibited the secretionof insulin and incretins.Althoughblackcurrants are
likely to be consumed only sporadically in the general population, other
berries contain different proﬁles of anthocyanins. Regular consumption of
any combination of these as main meals or with snack foods may help
lower postprandial glycemia which may reduce the vascular burden of
glucose-induced oxidative stress and endothelial dysfunction [19,20]
involved in the progression of atherosclerosis. This evidence supports
current dietary advice that a predominantly plant-based diet may help
prevent CVD and T2D and suggests one of many routes by which cardio-
metabolic protection can occur.
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